2023, Vol: 13, Issue: 11

13 / 11Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2022; 12(9): 1448-1453

doi: 10.5455/njppp.2022.12.07363202230072022

Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India

Kanagasanthosh K, Saravana K S, Indra A.

Abstract
Background: We assessed utilization patterns, profile of diagnoses, and fixed dose combination (FDC) with pregabalin in patients with various indications.

Aims and Objectives: The aim of the study was to estimate the prevalence of pregabalin prescribing pattern among the patients attending the various outpatient departments (OPDs) of a tertiary care hospital at Trichy in South India.

Materials and Methods: A hospital-based prospective observational study was planned and conducted over a period of 12 months. Patients who attended the various OPDs were included in the study. Prescriptions were collected from the respective consulting departments and pharmacy.

Results: A total of 2490 patients prescription were analyzed. There was female preponderance (54.22%). Majority (45.74%) were in the age group of 51–64 years. General medicine was the highest (41.36%) visited patients. Neuropathic pain was the most prevalent disease condition among the various age group (57.67%), and predominant between 40 and 65 years (55.86%). Total of 12,220 drugs were prescribed, most frequently prescribed drugs belong to category of plain pregabalin 75 mg (53.37%) with female predominance, with maximum prescription from the medicine department (40%). Among the FDC, pregabalin 75 mg with nortriptyline 10 mg was the highest prescribed drug by the orthopedic department (41%). Extended release pregabalin 75 mg (13.04%) and low dose pregabalin 50 mg (2.19%) were also prescribed in our study.

Conclusion: The prevalence of pregabalin prescription was maximum to neuropathic pain followed by radicular pain, trigeminal neuralgia, claudication, and herpetic neuralgia. Plain pregabalin 75 mg is preferred by most of the departments, few preferred extended release of 75 mg. Among the various FDC, pregabalin 75 mg with nortriptyline 10 mg and with methylcobalamine 750 mcg were prescribed by many departments.

Key words: Pregabalin; Prevalence; Prescribing Trends; Fixed Dose Combination

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Kanagasanthosh K Articles by Saravana K S Articles by Indra A
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

K K, S SK, A I. Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India. Natl J Physiol Pharm Pharmacol. 2022; 12(9): 1448-1453. doi:10.5455/njppp.2022.12.07363202230072022

Web Style

K K, S SK, A I. Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India. https://www.njppp.com/?mno=83649 [Access: November 02, 2023]. doi:10.5455/njppp.2022.12.07363202230072022

AMA (American Medical Association) Style

K K, S SK, A I. Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India. Natl J Physiol Pharm Pharmacol. 2022; 12(9): 1448-1453. doi:10.5455/njppp.2022.12.07363202230072022

Vancouver/ICMJE Style

K K, S SK, A I. Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India. Natl J Physiol Pharm Pharmacol. (2022), [cited November 02, 2023]; 12(9): 1448-1453. doi:10.5455/njppp.2022.12.07363202230072022

Harvard Style

K, K., S, . S. K. & A, . I. (2022) Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India. Natl J Physiol Pharm Pharmacol, 12 (9), 1448-1453. doi:10.5455/njppp.2022.12.07363202230072022

Turabian Style

K, Kanagasanthosh, Saravana K S, and Indra A. 2022. Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India. National Journal of Physiology, Pharmacy and Pharmacology, 12 (9), 1448-1453. doi:10.5455/njppp.2022.12.07363202230072022

Chicago Style

K, Kanagasanthosh, Saravana K S, and Indra A. "Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 1448-1453. doi:10.5455/njppp.2022.12.07363202230072022

MLA (The Modern Language Association) Style

K, Kanagasanthosh, Saravana K S, and Indra A. "Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India." National Journal of Physiology, Pharmacy and Pharmacology 12.9 (2022), 1448-1453. Print. doi:10.5455/njppp.2022.12.07363202230072022

APA (American Psychological Association) Style

K, K., S, . S. K. & A, . I. (2022) Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India. National Journal of Physiology, Pharmacy and Pharmacology, 12 (9), 1448-1453. doi:10.5455/njppp.2022.12.07363202230072022

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article


About National Journal of Physiology, Pharmacy and Pharmacology National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal. The journal is having open access polic ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272